| A review of the international early recommendations for departments organization and cancer management priorities during the global COVID-19 pandemic: applicability in low-and … Y Belkacemi, N Grellier, S Ghith, K Debbi, G Coraggio, A Bounedjar, ... European Journal of Cancer 135, 130-146, 2020 | 45 | 2020 |
| Survey of utilization of multidisciplinary management tumor boards in Arab countries NS El Saghir, N El-Asmar, C Hajj, T Eid, S Khatib, A Bounedjar, D Ajarim, ... The Breast 20, S70-S74, 2011 | 39 | 2011 |
| Epidemiology of breast cancer in women based on diagnosis data from oncologists and senologists in Algeria F Smaili, A Boudjella, A Dib, S Braikia, H Zidane, R Reggad, A Bendib, ... Cancer Treatment and Research Communications 25, 100220, 2020 | 13 | 2020 |
| OSSMAR: an observational study to describe the use of sunitinib in real-life practice for the treatment of metastatic renal cell carcinoma M Ghosn, R Eid, E Hamada, H Abdel Azim, J Zekri, M Al-Mansour, ... Journal of global oncology 5, 1-10, 2019 | 10 | 2019 |
| The study of druggable targets in nonsquamous non-small-cell lung cancer in the Middle East and North Africa AR Jazieh, A Bounedjar, F Al Dayel, S Fahem, A Tfayli, K Rasul, H Jaafar, ... Journal of Immunotherapy and Precision Oncology 2 (1), 4-7, 2019 | 10 | 2019 |
| Neoadjuvant endocrine therapy with or without palbociclib in low-risk patients: a phase III randomized double-blind SAFIA trial K Alsaleh, H Al Zahwahry, A Bounedjar, M Oukkal, A Saadeddine, ... Journal of cancer research and clinical oncology 149 (9), 6171-6179, 2023 | 7 | 2023 |
| Response to induction neoadjuvant hormonal therapy using upfront 21-gene breast recurrence score assay—results from the SAFIA phase III trial K AlSaleh, H Al Zahwahry, A Bounedjar, M Oukkal, A Saadeddine, ... JCO Global Oncology 7, 811-819, 2021 | 7 | 2021 |
| National approaches to managing cancer care: responses of countries in the MENA region to the COVID-19 pandemic Z Benbrahim, L Mula-Hussain, HO Al-Shamsi, N El Saghir, M Al Asiri, ... ecancermedicalscience 15, 2021 | 7* | 2021 |
| Predictors of poor precautionary practices towards COVID-19 among cancer patients AR Jazieh, AA Bensalem, A Bounedjar, Z Benbrahim, MO Alorabi, ... Future Oncology 17 (35), 4871-4882, 2021 | 6 | 2021 |
| Guidelines,“minimal requirements” and standard of care in glioblastoma around the Mediterranean Area: A report from the AROME (Association of Radiotherapy and Oncology of the … Y Belkacemi, S Bolle, F Bourdeaut, P Collin, P Cornu, JY Delatre, ... Critical Reviews in Oncology/Hematology 98, 189-199, 2016 | 6 | 2016 |
| General Oncology Care in Algeria A Bounedjar, MA Melzi, H Idir, N Heba Cancer in the Arab World, 15-30, 2022 | 5 | 2022 |
| Incidence of lung cancer in males and females in Algeria: The lung cancer registry in Algeria (LuCaReAl) A Bounedjar, R Benkali, L Badoui, M Abada, A Moumeni, A Marouani, ... Cancer Epidemiology 69, 101799, 2020 | 5 | 2020 |
| Expression of immune response markers in Arab patients with lung cancer AR Jazieh, A Bounedjar, H Bamefleh, T Alfayea, HQ Almaghraby, ... JCO Global Oncology 6, 1218-1224, 2020 | 5 | 2020 |
| Intravesical gemcitabine (G) single agent as adjuvant chemotherapy in superficial transitional cell carcinoma (TCC) of bladder K Bouzid, R Ferhat, A Bounedjar, H Mahfouf, F Smaili, K Adjali Journal of Clinical Oncology 22 (14_suppl), 4601-4601, 2004 | 5 | 2004 |
| Cancer burden among Arab world males in 2020: The need for a better approach to improve outcome L Mula-Hussain, H Mahdi, ZS Ramzi, M Tolba, MS Zaghloul, Z Benbrahim, ... JCO Global Oncology 8, e2100407, 2022 | 4 | 2022 |
| Epidemiology of breast cancer in young women in the southern part of the Mediterranean Area Y Belkacemi, PG Tsoutsou, H Boussen, F Geara, A Bounedjar, A Benider J Can Epi Treat 4, 1-7, 2017 | 4 | 2017 |
| Thérapies anticancéreuses ciblées: vers une nouvelle toxicologie? S Aissi, MB Mrad, S Zarraa, A Bounedjar, S Laabidi, H Boussen Pathologie Biologie 60 (4), 234-238, 2012 | 4 | 2012 |
| Final result for SAFIA trial for neoadjuvant palbociclib in patients with operable luminal breast cancer responding to fulvestrant. KA Al-Saleh, HM El Zawahry, A Bounedjar, M Oukkal, A Saadeddin, ... Journal of Clinical Oncology 40 (16_suppl), 596-596, 2022 | 3 | 2022 |
| Prediction of response to neoadjuvant hormonal therapy (NAHT) using upfront oncotype Dx recurrence score (RS): Results from the SAFIA phase III trial. KA Al-Saleh, A Bounedjar, M Oukkal, H Mahfouf, K Bouzid, A Bensalem, ... Journal of Clinical Oncology 38 (15_suppl), 594-594, 2020 | 3 | 2020 |
| Patterns of diagnostic procedures for lung cancer pathology in the Middle East and North Africa AR Jazieh, A Bounedjar, F Al Dayel, S Fahem, A Tfayli, K Rasul, H Jaafar, ... Journal of Thoracic Disease 11 (12), 5162, 2019 | 3 | 2019 |
